Skip to main content

Table 1 Demographic data and T cell counts in the study cohort

From: Identification of CD8+ T cell subsets that normalize in early-treated people living with HIV receiving antiretroviral therapy

Parameter

HIV sample 1

Median (IQR)

HIV sample 2

Median (IQR)

Seronegative

Median (IQR)

P-value

HIV sample 1 vs HIV sample 21

P-value

HIV sample 1 vs. seronegative2

P-value

HIV sample 2 vs. seronegative2

n

16

15

NA

NA

NA

Age (years)

33 (24–52)

27 (25–28)

NA

0.16

NA

Estimated date of serodiagnosis (Months after HIV diagnosis)

36 (25–100)

NA

NA

NA

NA

CD4+ T cells count (cells/μL)

642 (533–705)

854 (811–1122)

634 (535–1192)

0.0007

0.49

0.08

CD8+ T cells count (cells/μL)

830 (598–1078)

948 (552–1265)

460 (361–537)

0.27

< 0.0001

0.0007

CD4:CD8 ratio

0.75 (0.59–0.99)

1.15 (0.72–1.58)

1.6 (1.4–2.3)

0.0037

< 0.0001

0.0163

  1. 1Wilcoxon test
  2. 2Mann–Whitney test. NA: Does not apply; IQR: interquartile range